Shawn Mikael Cross is no longer serving in their position at GT Biopharma, Inc.

Jul 05, 2018
Board and Executive Moves
Background Information
GT Biopharma, Inc. engages in the development and commercialization of novel immuno-oncology products. Its products include OXS-1550, OXS-1615, OXS-3550, OXS-3550, PainBrake, GTP-004, and GTP-011. The company was founded in 1965 and is headquartered in Beverly Hills, CA.